SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-21-005808
Filing Date
2021-11-18
Accepted
2021-11-18 14:00:12
Documents
1
Period of Report
2021-11-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3240
  Complete submission text file 0001683168-21-005808.txt   4628
Mailing Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Inc. (Issuer) CIK: 0001819663 (see all company filings)

IRS No.: 843998117 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5000 TRESSDALE DRIVE GIBSONIA PA 15044
Business Address
Mehalick David (Reporting) CIK: 0001846623 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-56194 | Film No.: 211423776